Jetstream Backs AI Startup, Novo Nordisk Teams with OpenAI, Amazon's New AI Tool

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we highlight several significant developments, including Jetstream Venture Fund's investment in Hill Research, a startup focused on enhancing pharmaceutical research through AI. Additionally, Function has acquired Getlabs to integrate AI into mobile healthcare services, aiming to improve accessibility and service delivery.

In other news, Senhwa Biosciences has secured substantial funding to support its AI-driven drug discovery efforts, while Novo Nordisk partners with OpenAI to boost efficiency in drug development. We also cover Harbinger Health's launch of an AI-driven cancer detection test and ProQR Therapeutics' collaboration with Ginkgo Bioworks to enhance AI drug discovery. Stay tuned for more insights into how AI is transforming healthcare and life sciences.

Jetstream Invests in AI Startup Hill Research

Jetstream Venture Fund has made its first AI-focused investment in Hill Research, a startup working on an AI platform to streamline clinical pharmaceutical research. Read more

Function Acquires Getlabs for AI-Driven Healthcare

Function has acquired Getlabs, a mobile healthcare platform, to improve access to health services by enabling at-home or workplace services. The acquisition seeks to integrate AI technology to enhance service delivery and remove healthcare access barriers. Read more

Senhwa Biosciences Secures NT$500 Million for AI Drug Development

Senhwa Biosciences has signed an agreement with GEM YIELD BAHAMAS LIMITED to receive up to NT$500 million in funding. The investment will support Senhwa's AI-driven drug discovery and global expansion, focusing on cancer immunotherapy. Read more

Kazia Therapeutics Licenses SETDB1 Inhibitor Platform

Kazia Therapeutics Limited has announced the in-licensing of a SETDB1-targeted drug development platform from QIMR Berghofer, utilizing AI for developing a candidate to combat immunotherapy-resistant tumors. Read more

Novo Nordisk Partners with OpenAI for Drug Development

Danish drugmaker Novo Nordisk has teamed up with OpenAI to leverage AI in drug discovery and manufacturing, aiming to boost efficiency and productivity. Read more

Accuity Appoints New Chief Product and Strategy Officer

Accuity has appointed Cindy Klain as the Chief Product and Strategy Officer to lead product management and corporate strategy, focusing on AI innovations in healthcare. Read more

Harbinger Health Introduces AI-Driven Cancer Detection Tests

Harbinger Health has launched RESOLVE™, a new AI-driven blood-based test category for multi-cancer detection, aimed at improving diagnosis speed and reducing mortality rates. Read more

Aegis Ventures and Wavelet Medical Launch AI Fetal Monitoring Platform

Wavelet Medical, in partnership with Aegis Ventures, has developed an AI-powered fetal EEG monitoring platform to detect fetal brain distress, supported by $7 million in funding. Read more

Sunbound Launches AI-First Revenue OS

Sunbound has introduced its AI-First Revenue OS, sunbound.ai, following a significant increase in its annual payment volume to over $1 billion. The platform aims to enhance revenue management for senior living operators by automating payment collection and claims management. Read more

Axxess 2026 AGILE Conference on AI in Home Healthcare

The 2026 AGILE Conference by Axxess will focus on responsible AI adoption in home healthcare, addressing regulatory and governance challenges. Read more

Onix Launches Personal Intelligence® for Health and Wellness

Onix has introduced Personal Intelligence®, an AI platform focused on health and wellness, emphasizing user privacy and expert guidance. Read more

L7 Informatics Unveils AI Solution for Life Sciences

L7 Informatics has launched L7|SYNAPSE™, an AI platform aimed at improving operational reliability and security in regulated life sciences by using natural language interactions grounded in specific organizational knowledge. Read more

Tuesday Health and Humana Partner for AI-Driven Palliative Care

Tuesday Health and Humana have announced a partnership to enhance value-based palliative care in Texas using AI innovations, starting June 1, 2026. Read more

Briya Expands Data Network for AI Medical Research

Briya has expanded its global data network to include over 120 million patient records, enhancing AI-driven medical research capabilities with diverse datasets from multiple regions. Read more

Amazon Launches AI Tool for Drug Discovery

Amazon Web Services has introduced 'Amazon Bio Discovery', an AI tool designed to accelerate early-stage drug discovery by enabling researchers to run complex workflows without coding. Read more

Caristo Diagnostics Appoints New CEO

Caristo Diagnostics, a University of Oxford spinout, has appointed Stephen M. Deitsch as CEO to advance AI technology in cardiovascular care. Read more

Spirographic AI Launches Drug Target Prediction Platform

Spirographic AI has introduced a new platform for tissue-specific polypharmacology, enhancing drug target identification and side effect prediction. Developed by Brandy Stoffel, it achieves 54% primary target accuracy and analyzes 195 receptor targets across 8 organ systems. Read more

Anthropic Appoints Vas Narasimhan to Board

Vas Narasimhan, CEO of Novartis, has joined the Board of Directors at Anthropic. His appointment aligns with the company's mission to develop AI for humanity's long-term benefit. Read more

Technogym and Google Cloud Partner on AI for Wellness

Technogym has partnered with Google Cloud to integrate AI technologies into its health and wellness ecosystem, aiming to enhance personalized experiences and improve predictive training. Read more

Xtalks Webinar on Hematologic Malignancy Drug Development

A free webinar by Xtalks will discuss advancements in hematologic malignancy drug development, featuring speakers from NeoGenomics and Fortrea. Read more

ProQR and Ginkgo Bioworks Partner for AI Drug Discovery

ProQR Therapeutics has partnered with Ginkgo Bioworks to enhance AI-driven drug discovery using Ginkgo's lab technology. An AI Advisory Board has been established to guide ProQR's strategy. Read more

Decoy Therapeutics Partners with Google Cloud for AI in Antiviral Development

Decoy Therapeutics has teamed up with Google Cloud to enhance its AI capabilities in designing antiviral peptides, aiming to speed up the discovery of antiviral treatments. Read more

Categories

Companies

Resources

Jetstream Backs AI Startup, Novo Nordisk Teams with OpenAI, Amazon's New AI Tool - Life AI Weekly #63

We hope you enjoyed this article.

More from: Life Sciences

Subscribe to Life AI Weekly